Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders: a Multiple Baseline Online SCED Study

NCT06858566 is registered in ClinicalTrials.gov with Fondation Ildys as lead sponsor.

NCT NCT06858566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06858566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders: a Multiple Baseline Online SCED Study
Lead sponsor
Fondation Ildys
Phase
Not applicable
Overall status
Recruiting
Start date
March 21, 2025
Completion date
February 24, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

writing disorder